14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Jan 30, 2020 $7.14 $7.14 $6.23 $6.43 522 314
Jan 29, 2020 $7.25 $7.39 $7.11 $7.36 180 042
Jan 28, 2020 $8.25 $8.45 $7.05 $7.27 953 052
Jan 27, 2020 $7.11 $8.02 $7.00 $7.86 703 273
Jan 24, 2020 $8.20 $8.20 $7.08 $7.40 770 516
Jan 23, 2020 $7.00 $8.45 $6.51 $8.37 3 195 176
Jan 22, 2020 $8.29 $10.42 $8.19 $9.86 2 317 188
Jan 21, 2020 $8.02 $8.34 $7.99 $8.25 364 809
Jan 17, 2020 $8.24 $8.53 $7.97 $8.16 445 213
Jan 16, 2020 $8.28 $8.36 $7.90 $8.13 518 006
Jan 15, 2020 $8.36 $8.63 $8.00 $8.17 841 564
Jan 14, 2020 $7.45 $8.45 $7.36 $8.34 1 179 093
Jan 13, 2020 $8.03 $8.10 $7.41 $7.53 1 024 683
Jan 10, 2020 $8.60 $9.32 $7.57 $7.84 6 482 703
Jan 09, 2020 $6.65 $9.50 $5.90 $9.27 42 202 893
Jan 08, 2020 $4.25 $4.28 $4.13 $4.16 136 731
Jan 07, 2020 $4.15 $4.38 $4.11 $4.27 202 412
Jan 06, 2020 $4.22 $4.26 $4.11 $4.13 149 246
Jan 03, 2020 $4.17 $4.47 $4.13 $4.18 149 698
Jan 02, 2020 $4.51 $4.57 $4.10 $4.15 267 260
Dec 31, 2019 $4.40 $4.59 $4.20 $4.52 173 522
Dec 30, 2019 $4.72 $4.85 $4.12 $4.40 369 703
Dec 27, 2019 $4.91 $5.03 $4.28 $4.74 313 934
Dec 26, 2019 $4.86 $5.49 $4.75 $4.92 821 350
Dec 24, 2019 $3.99 $5.30 $3.96 $4.86 996 232
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT